- PCR-based
- Genetic Sequencing-based
- Hybridization-based
- Microarray-based
PoC Molecular Diagnostics Market size was valued at USD 2.50 billion in 2022 and is expected to reach USD 3.9 billion by 2029, at a CAGR of 11.69% from 2023-2029. Rising focus on decentralized diagnostics, increasing worldwide prevalence of infectious diseases, improved need for accurate and faster testing methods, growing awareness regarding benefits of early disease diagnosis and awareness amongst people will increase demand for point of care molecular diagnostics and growing demand for CLIA-waived molecular POC tests are some key factors fostering the market growth. However, factors such as Inadequate Reimbursements and strict government regulations are hindering the market growth. This report studies global PoC molecular diagnostics market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Global Poc Molecular Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.69%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
PoC Molecular Diagnostics Market Dynamics
Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. Many tests have received clinical laboratory improvement amendments (CLIA) waivers that enable POC use. CLIA-waived tests are typically simple and have a low risk for an incorrect result. With CLIA waiver, these tests can be used in a wide range of settings including pharmacy-based clinics, urgent care centers and hospitals, increasing access to testing and streamlining care. Another feature of many POC molecular flu tests is room temperature storage of test components, creating a more versatile lab footprint and allowing testing to be performed in a variety of locations.
Asia-Pacific Got Significant Share
PoC Molecular Diagnostics Market Regional Analysis
Asia Pacific accounted for larger revenue share in global PoC molecular diagnostics market with considerable CAGR. The growth in this region is due to a larger population base in need for clinical testing, potential cost-effective implementation of PoC molecular tests and lack of sophisticated central laboratory testing service. China and India are the major contributors for the growth of the market in the region. North America held substantial market growth during estimated period owing to high R&D investments by governments and presence of technologically advanced medical framework.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The PoC molecular diagnostics market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Poc Molecular Diagnostics Market Segmentation
By Technology
By Test Location
- OTC
- POC
By Application
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
By End User
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Other users
Frequently Asked Questions
The poc molecular diagnostics market is projected to expand at a CAGR of 11.69% during the forecast period
Abbott Laboratories, Danaher Corporation, Biomérieux Sa, Roche Diagnostics, Quidel, Meridian Bioscience, Mesa Biotech, Genepoc, DxNA, Atlas Genetics, Spartan Bioscience
North America is the fastest-growing region for poc molecular diagnostics market
| 1. Executive Summary |
| 2. Global PoC Molecular Diagnostics Market Introduction |
| 2.1.Global PoC Molecular Diagnostics Market - Taxonomy |
| 2.2.Global PoC Molecular Diagnostics Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Test Location |
| 2.2.3.Application |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global PoC Molecular Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global PoC Molecular Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global PoC Molecular Diagnostics Market By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. PCR-based |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Genetic Sequencing-based |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Hybridization-based |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Microarray-based |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global PoC Molecular Diagnostics Market By Test Location, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. OTC |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. POC |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global PoC Molecular Diagnostics Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Infectious Diseases |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Oncology |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hematology |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Prenatal Testing |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Endocrinology |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Other Applications |
| 7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Global PoC Molecular Diagnostics Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Decentralized Labs |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Hospitals |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Home-care |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Assisted Living Healthcare Facilities |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Other users |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global PoC Molecular Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.PCR-based |
| 10.1.2.Genetic Sequencing-based |
| 10.1.3.Hybridization-based |
| 10.1.4.Microarray-based |
| 10.2. Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.OTC |
| 10.2.2.POC |
| 10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Infectious Diseases |
| 10.3.2.Oncology |
| 10.3.3.Hematology |
| 10.3.4.Prenatal Testing |
| 10.3.5.Endocrinology |
| 10.3.6.Other Applications |
| 10.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Decentralized Labs |
| 10.4.2.Hospitals |
| 10.4.3.Home-care |
| 10.4.4.Assisted Living Healthcare Facilities |
| 10.4.5.Other users |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.PCR-based |
| 11.1.2.Genetic Sequencing-based |
| 11.1.3.Hybridization-based |
| 11.1.4.Microarray-based |
| 11.2. Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.OTC |
| 11.2.2.POC |
| 11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Infectious Diseases |
| 11.3.2.Oncology |
| 11.3.3.Hematology |
| 11.3.4.Prenatal Testing |
| 11.3.5.Endocrinology |
| 11.3.6.Other Applications |
| 11.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Decentralized Labs |
| 11.4.2.Hospitals |
| 11.4.3.Home-care |
| 11.4.4.Assisted Living Healthcare Facilities |
| 11.4.5.Other users |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.PCR-based |
| 12.1.2.Genetic Sequencing-based |
| 12.1.3.Hybridization-based |
| 12.1.4.Microarray-based |
| 12.2. Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.OTC |
| 12.2.2.POC |
| 12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Infectious Diseases |
| 12.3.2.Oncology |
| 12.3.3.Hematology |
| 12.3.4.Prenatal Testing |
| 12.3.5.Endocrinology |
| 12.3.6.Other Applications |
| 12.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Decentralized Labs |
| 12.4.2.Hospitals |
| 12.4.3.Home-care |
| 12.4.4.Assisted Living Healthcare Facilities |
| 12.4.5.Other users |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.PCR-based |
| 13.1.2.Genetic Sequencing-based |
| 13.1.3.Hybridization-based |
| 13.1.4.Microarray-based |
| 13.2. Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.OTC |
| 13.2.2.POC |
| 13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Infectious Diseases |
| 13.3.2.Oncology |
| 13.3.3.Hematology |
| 13.3.4.Prenatal Testing |
| 13.3.5.Endocrinology |
| 13.3.6.Other Applications |
| 13.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Decentralized Labs |
| 13.4.2.Hospitals |
| 13.4.3.Home-care |
| 13.4.4.Assisted Living Healthcare Facilities |
| 13.4.5.Other users |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.PCR-based |
| 14.1.2.Genetic Sequencing-based |
| 14.1.3.Hybridization-based |
| 14.1.4.Microarray-based |
| 14.2. Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.OTC |
| 14.2.2.POC |
| 14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Infectious Diseases |
| 14.3.2.Oncology |
| 14.3.3.Hematology |
| 14.3.4.Prenatal Testing |
| 14.3.5.Endocrinology |
| 14.3.6.Other Applications |
| 14.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Decentralized Labs |
| 14.4.2.Hospitals |
| 14.4.3.Home-care |
| 14.4.4.Assisted Living Healthcare Facilities |
| 14.4.5.Other users |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1. Abbott Laboratories |
| 15.2.2. Danaher Corporation |
| 15.2.3. Biomerieux Sa |
| 15.2.4. Roche Diagnostics |
| 15.2.5. Quidel |
| 15.2.6. Meridian Bioscience |
| 15.2.7. Mesa Biotech |
| 15.2.8. Genepoc |
| 15.2.9. DxNA |
| 15.2.10. Atlas Genetics |
| 15.2.11. Spartan Bioscience |
| 15.2.12. Biocartis |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Abbott Laboratories
- Danaher Corporation
- Biomerieux Sa
- Roche Diagnostics
- Quidel
- Meridian Bioscience
- Mesa Biotech
- Genepoc
- DxNA
- Atlas Genetics
- Spartan Bioscience
- Biocartis